Age Normalized Testosterone Peaks at Series B for Male Startup Founders
Jordan Moradian,
Michael Dubrovsky,
Megha Sama,
Pavel Korecky,
Sidarth Kulkarni,
Yaniv Goder and
Diedrik Vermeulen
Papers from arXiv.org
Abstract:
In a study of 107 male Y Combinator founders, a surprising correlation between age-normalized testosterone and company stage was uncovered. Testosterone, a hormone associated with confidence, dominance, and drive, increased by 55.7% from pre-seed to seed funding, peaking at the Series B stage, where levels were 99.6% higher than pre-seed. After series B funding, testosterone was observed to drop by 42.2%, coinciding with a spike in cortisol levels. This age-normalized biomarker analysis supports the dual-hormone hypothesis, illustrating that early startup success fosters feelings of dominance and confidence, while later-stage pressures and stresses erode these feelings. An alternative interpretation of the data, which suggests the opportunity for a longitudinal study, is that male founders with higher testosterone are more likely to raise larger rounds of funding.
Date: 2024-11
New Economics Papers: this item is included in nep-ent
References: Add references at CitEc
Citations:
Downloads: (external link)
http://arxiv.org/pdf/2411.03361 Latest version (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:arx:papers:2411.03361
Access Statistics for this paper
More papers in Papers from arXiv.org
Bibliographic data for series maintained by arXiv administrators (help@arxiv.org).